YU215090A - Formulacija u obliku pilule za kontrolisano oslobađanje - Google Patents

Formulacija u obliku pilule za kontrolisano oslobađanje

Info

Publication number
YU215090A
YU215090A YU215090A YU215090A YU215090A YU 215090 A YU215090 A YU 215090A YU 215090 A YU215090 A YU 215090A YU 215090 A YU215090 A YU 215090A YU 215090 A YU215090 A YU 215090A
Authority
YU
Yugoslavia
Prior art keywords
formulation
pulled
controlled release
crohn
colitis
Prior art date
Application number
YU215090A
Other languages
English (en)
Serbian (sr)
Other versions
YU48583B (sh
Inventor
J. Ulmius
Original Assignee
Aktiebolaget Draco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20377544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU215090(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aktiebolaget Draco filed Critical Aktiebolaget Draco
Priority to SI9012150A priority Critical patent/SI9012150A/sl
Priority to HRP-2150/90A priority patent/HRP920632B1/xx
Publication of YU215090A publication Critical patent/YU215090A/sh
Publication of YU48583B publication Critical patent/YU48583B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Abstract

Formulacija u obliku pilule za kontrolisano oslobadanje njene sadrzine pretstavlja primenu odredjenih glukokor-tikosterioda u pravljenju farmaceutskih preparata za lecenje oralnim putem ulcerativnog kolitisa i odredenih aspekata Chronove bolesti.
YU215090A 1989-11-22 1990-11-13 Postupak za pripremanje formulacije u obliku pilule za oralno davanje YU48583B (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI9012150A SI9012150A (sl) 1989-11-22 1990-11-13 Oralni pripravek za zdravljenje vnetnih črevesnih bolezni
HRP-2150/90A HRP920632B1 (en) 1989-11-22 1992-09-30 Oral composition for the treatment of inflammatory bowel deseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903914A SE8903914D0 (sv) 1989-11-22 1989-11-22 Oral composition for the treatment of inflammatory bowel diseases

Publications (2)

Publication Number Publication Date
YU215090A true YU215090A (sr) 1996-01-09
YU48583B YU48583B (sh) 1998-12-23

Family

ID=20377544

Family Applications (1)

Application Number Title Priority Date Filing Date
YU215090A YU48583B (sh) 1989-11-22 1990-11-13 Postupak za pripremanje formulacije u obliku pilule za oralno davanje

Country Status (36)

Country Link
US (1) US6423340B1 (sh)
EP (1) EP0502092B1 (sh)
JP (1) JP3145111B2 (sh)
KR (1) KR0179042B1 (sh)
AT (1) ATE125445T1 (sh)
AU (1) AU643021B2 (sh)
CA (1) CA2071518C (sh)
DE (1) DE69021214T2 (sh)
DK (1) DK0502092T3 (sh)
EG (1) EG19642A (sh)
ES (1) ES2074698T3 (sh)
FI (2) FI104949B (sh)
GR (1) GR3017691T3 (sh)
HK (1) HK51897A (sh)
HR (1) HRP920632B1 (sh)
HU (2) HUT60630A (sh)
IE (1) IE74854B1 (sh)
IL (1) IL96415A (sh)
IS (1) IS1858B (sh)
LT (1) LT3696B (sh)
LV (1) LV10183B (sh)
MY (1) MY104535A (sh)
NO (1) NO304010B1 (sh)
NZ (1) NZ235807A (sh)
PL (1) PL166506B1 (sh)
PT (1) PT95946A (sh)
RU (1) RU2134104C1 (sh)
SA (1) SA90110123B1 (sh)
SE (1) SE8903914D0 (sh)
SG (1) SG54210A1 (sh)
SI (1) SI9012150A (sh)
TW (1) TW250435B (sh)
UA (1) UA37196C2 (sh)
WO (1) WO1991007172A1 (sh)
YU (1) YU48583B (sh)
ZA (1) ZA908777B (sh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
BR9307746A (pt) * 1993-01-08 1995-11-14 Astra Ab Derivados de esteróides especificos para otratamento de cólon e ileo
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE4332394A1 (de) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
CA2271560C (en) * 1996-11-15 2003-09-23 Mayo Foundation For Medical Education And Research Pharmaceutical dosage form for colonic delivery
SE9604751D0 (sv) 1996-12-20 1996-12-20 Astra Ab New therapy
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
GB9824604D0 (en) 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
SE9902673D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
US8263582B2 (en) * 2001-03-15 2012-09-11 Soligenix, Inc. Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
DE10250543A1 (de) * 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
DE60323138D1 (de) 2002-12-12 2008-10-02 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
WO2004087109A1 (ja) * 2003-03-27 2004-10-14 Hisamitsu Pharmaceutical Co., Inc. 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
DE602004028497D1 (de) * 2003-09-15 2010-09-16 Nycomed Gmbh Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
JP5563735B2 (ja) 2004-06-16 2014-07-30 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド Ｐｐｉ多回剤形
US20070243184A1 (en) * 2005-11-08 2007-10-18 Steven Fischkoff Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
CA2684655A1 (en) * 2007-03-26 2008-10-02 Teikoku Seiyaku Co., Ltd. Oral pharmaceutical preparation for colon-specific delivery
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
AU2009298139B2 (en) * 2008-10-03 2015-02-19 Dr. Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
US8945616B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
WO2012106722A2 (en) * 2011-02-04 2012-08-09 Optimer Pharmaceuticals, Inc. Treatment of bacterial infections
MD480Z5 (ro) * 2011-07-07 2012-09-30 Эльвира АНДОН Metodă de tratament al colitei ulceroase nespecifice acute
HUE036187T2 (hu) 2012-04-30 2018-06-28 Tillotts Pharma Ag Késleltetett leadású gyógyszerkészítmény
UA117260C2 (uk) 2013-10-29 2018-07-10 Тиллоттс Фарма АГ Лікарський препарат з відстроченим вивільненням
JP2018530535A (ja) * 2015-09-11 2018-10-18 サン・ファーマシューティカル・インダストリーズ・リミテッド ブデゾニドの経口医薬剤形
CN105663091A (zh) * 2016-01-28 2016-06-15 上海信谊百路达药业有限公司 一种布地奈德肠溶缓释胶囊及其制备方法
CN108601744B (zh) * 2016-02-09 2022-01-04 阿尔比里奥公司 口服考来烯胺制剂及其用途
JP6954927B2 (ja) * 2016-02-09 2021-10-27 アルビレオ・アクチボラグ 経口コレスチラミン製剤及びその使用
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996356A (en) 1969-07-02 1976-12-07 Hoffmann-La Roche Inc. Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
SE378109B (sh) 1972-05-19 1975-08-18 Bofors Ab
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
SE8003805L (sv) 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
SE8008524L (sv) 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
SE8306370D0 (sv) 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
US4708867A (en) 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4606940A (en) 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation
DE3536267A1 (de) 1985-10-11 1987-04-16 Bayer Ag Azofarbstoffe sowie fluessigkristallines material enthaltend azofarbstoffe
SE8506015D0 (sv) 1985-12-19 1985-12-19 Draco Ab Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
GB8630913D0 (en) * 1986-12-24 1987-02-04 Glaxo Group Ltd Pharmaceutical compositions
US4966770A (en) 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
DE10307386A1 (de) 2003-02-21 2004-09-09 Dieter Wildfang Gmbh Verfahren zum außenseitigen Beschichten eines sanitären Auslaufteiles sowie sanitäres Auslaufteil

Also Published As

Publication number Publication date
KR0179042B1 (ko) 1999-03-20
LTIP1751A (en) 1995-07-25
CA2071518C (en) 2002-11-12
IS1858B (is) 2003-03-27
HUT60630A (en) 1992-10-28
IE904170A1 (en) 1991-05-22
MY104535A (en) 1994-04-30
FI104949B (fi) 2000-05-15
PL166506B1 (pl) 1995-05-31
NO922004L (no) 1992-05-21
ZA908777B (en) 1991-07-31
KR920703025A (ko) 1992-12-17
HU216836B (hu) 1999-09-28
UA37196C2 (uk) 2001-05-15
HK51897A (en) 1997-05-02
FI19991893A (fi) 1999-09-06
NO922004D0 (no) 1992-05-21
EP0502092A1 (en) 1992-09-09
EP0502092B1 (en) 1995-07-26
HRP920632A2 (en) 1995-04-30
SA90110123B1 (ar) 1999-06-06
DE69021214D1 (de) 1995-08-31
FI922325A (fi) 1992-05-21
EG19642A (en) 1995-08-30
TW250435B (sh) 1995-07-01
IL96415A0 (en) 1991-08-16
LT3696B (en) 1996-02-26
DK0502092T3 (da) 1995-12-27
GR3017691T3 (en) 1996-01-31
NO304010B1 (no) 1998-10-12
JP3145111B2 (ja) 2001-03-12
HRP920632B1 (en) 1999-10-31
IS3644A7 (is) 1991-05-23
US6423340B1 (en) 2002-07-23
SI9012150A (sl) 1998-08-31
HU9201700D0 (en) 1992-08-28
CA2071518A1 (en) 1991-05-23
AU643021B2 (en) 1993-11-04
IE74854B1 (en) 1997-08-13
LV10183A (lv) 1994-10-20
NZ235807A (en) 1993-02-25
SE8903914D0 (sv) 1989-11-22
FI922325A0 (fi) 1992-05-21
ES2074698T3 (es) 1995-09-16
WO1991007172A1 (en) 1991-05-30
DE69021214T2 (de) 1996-01-04
AU7786491A (en) 1991-06-13
SG54210A1 (en) 1998-11-16
PL287844A1 (en) 1991-12-02
JPH05501705A (ja) 1993-04-02
IL96415A (en) 1995-11-27
PT95946A (pt) 1991-09-13
RU2134104C1 (ru) 1999-08-10
LV10183B (en) 1995-08-20
YU48583B (sh) 1998-12-23
ATE125445T1 (de) 1995-08-15

Similar Documents

Publication Publication Date Title
YU215090A (sr) Formulacija u obliku pilule za kontrolisano oslobađanje
KR920002144A (ko) 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
EP0151989A3 (en) Means for the treatment of cardiac diseases
KR950700749A (ko) 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
KR950703972A (ko) 항혈전성 치료 및 암 예방을 위한 아세틸살리실산을 함유하는 경피 투여 시스템(transdermal administration system containing acetylsalicyliic acid for antithrombotic therapy and the prevention of cancer)
BG106171A (en) Compositions and uses of et743 for treating cancer
GB9103764D0 (en) Compositions
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
KR910005858A (ko) 지방산 요법
ATE141510T1 (de) Arzneimittel enthaltend cd14
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
KR900017599A (ko) 종양 치료용 약학 조성물
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
GR3030600T3 (en) Pharmaceutical pentapeptide compositions and methods of use thereof.
MD1780G2 (ro) Metodă de tratament al pacienţilor cu ciroze hepatice
NO920031D0 (no) Synergistisk middel for terapeutisk behandling, preparat inneholdende nevnte middel, og anvendelse av middelet for fremstilling av et legemiddelpreparat
ITMI913248A1 (it) Composizioni terapeutiche adatte per la somministrazione orale contenenti come principio attivo uno o piu' tioesteri del glutatione e procedimento per la preparazione dei suddetti principi attivi